acut
respiratori
infect
one
lead
caus
child
adult
morbid
mortal
throughout
world
william
et
al
determin
etiolog
diagnos
patient
respiratori
symptom
remain
challeng
clinic
laboratori
differenti
infect
caus
influenza
virus
caus
respiratori
virus
essenti
case
manag
illustr
influenza
pandem
mani
definit
ill
ili
use
worldwid
influenza
surveil
howev
sensit
posit
predict
valu
definit
significantli
vari
depend
respiratori
virus
commun
boivin
et
al
lee
et
al
thurski
et
al
identif
respiratori
virus
respons
ill
report
mani
countri
percentag
posit
swab
least
one
viru
rang
bellei
et
al
et
al
ren
et
al
buecher
et
al
renoi
et
al
razanajatovo
et
al
ill
attribut
wide
rang
respiratori
virus
includ
influenza
virus
adenovirus
adv
respiratori
syncyti
viru
rsv
enterovirus
ev
human
rhinoviru
hrv
parainfluenza
virus
piv
bellei
et
al
et
al
ren
et
al
buecher
et
al
renoi
et
al
razanajatovo
et
al
recent
sever
virus
associ
respiratori
infect
includ
human
metapneumoviru
hmpv
van
den
hoogen
et
al
human
coronaviru
van
der
hoek
et
al
human
coronaviru
woo
et
al
well
human
bocaviru
hbov
alland
et
al
three
novel
polyomavirus
kipyv
wupyv
mcpyv
detect
recent
respiratori
tract
human
howev
pathogen
remain
controversi
norja
et
al
et
al
influenza
pandem
provid
uniqu
opportun
investig
distribut
differ
virus
patient
ill
larg
sampl
gener
popul
studi
describ
epidemiolog
clinic
data
differ
respiratori
virus
identifi
circul
pandem
hombrouck
et
al
lee
et
al
raboni
et
al
smit
et
al
b
studi
describ
preval
virus
patient
suspect
influenza
gener
practition
sent
referr
center
nasal
swab
sampl
subsequ
laboratori
test
outbreak
june
januari
patient
present
ill
suspect
influenza
either
refer
gener
practition
consult
directli
doctor
group
set
specif
manag
suspect
patient
influenza
pandem
infecti
diseas
tropic
medicin
depart
north
hospit
marseil
franc
upon
admiss
patient
question
examin
nasal
swab
collect
test
poc
laboratori
rapid
influenza
diagnost
test
ridt
ninov
et
al
nougaired
et
al
obtain
oral
consent
epidemiolog
clinic
questionnair
complet
patient
wait
ridt
result
sent
back
poc
lab
patient
neg
ridt
result
return
home
isol
measur
recommend
result
assay
obtain
result
obtain
hr
later
patient
posit
sampl
contact
telephon
risk
factor
propos
hospit
oseltamivir
therapi
isol
measur
without
risk
factor
symptomat
treatment
recommend
ridt
perform
use
directigen
ez
influenza
b
test
bd
ez
flu
b
becton
dickinson
accord
manufactur
instruct
rna
extract
respiratori
sampl
prepar
ridt
spike
phage
intern
control
ninov
et
al
rna
extract
elut
use
biorobot
workstat
viru
mini
kit
qiagen
courtaboeuf
franc
revers
transcript
perform
taqman
revers
transcript
kit
appli
biosystem
branchburg
nj
rna
buffer
mm
dntp
hexam
dilut
multiscrib
rnase
inhibitor
final
volum
cycl
program
min
min
min
sampl
two
revers
transcript
final
volum
done
result
volum
cdna
use
pcr
test
pcr
assay
perform
use
qpcr
rox
kit
eurogentec
anger
franc
cdna
mastermix
primer
mm
probe
mm
combin
stratagen
qpcr
system
agil
technolog
la
jolla
ca
primer
probe
use
studi
list
tabl
cycl
program
conduct
min
min
cycl
sec
sec
step
extract
rt
pcr
monitor
univers
intern
control
assay
base
use
dna
rna
bacteriophag
describ
previous
ninov
et
al
pcr
detect
bacteriophag
perform
parallel
pcr
use
cycl
program
final
volum
cdna
mastermix
primer
mm
probe
mm
sampl
run
valid
result
obtain
ninov
et
al
questionnair
enter
anonym
databas
epidata
center
diseas
control
prevent
criteria
ill
cdc
atlanta
ga
data
analyz
spss
version
spss
inc
chicago
il
identifi
clinic
characterist
group
patient
potenti
variabl
first
assess
individu
univari
model
p
valu
measur
qualit
variabl
use
pearson
test
fisher
exact
test
continu
variabl
use
test
correl
assess
use
spearman
test
variabl
p
valu
retain
enter
multivari
logist
regress
analysi
among
patient
posit
among
patient
neg
result
sampl
randomli
chosen
sampl
still
avail
patient
seen
wave
patient
seen
wave
remain
patient
period
test
respiratori
virus
posit
least
one
viru
posit
hrv
nine
hcov
five
ev
five
one
three
four
adv
two
hmpv
remain
sampl
found
neg
virus
test
studi
fig
first
wave
patient
posit
swab
among
patient
test
virus
posit
swab
hrv
neg
swab
second
wave
percentag
patient
test
posit
significantli
higher
observ
first
wave
p
ci
wherea
among
patient
test
virus
hrv
consist
preval
p
among
sampl
test
virus
identifi
five
patient
one
hrv
adv
one
hrv
one
ev
hcov
one
hmpv
adv
one
piv
adv
patient
hospit
patient
characterist
stratifi
infect
statu
tabl
ii
case
patient
present
ill
accord
definit
propos
cdc
follow
symptom
temperatur
either
cough
sore
throat
babcock
et
al
cdc
three
patient
asymptomat
among
ill
patient
posit
test
patient
posit
hrv
piv
hcov
adv
hmpv
respect
tabl
iii
patient
hospit
later
confirm
infect
test
posit
hrv
patient
test
posit
significantli
younger
year
ci
test
neg
year
ci
p
analyz
univari
analysi
cough
fever
rhinorrhea
chill
vomit
conjunct
hyperemia
dyspnea
significantli
preval
patient
odd
ratio
rang
tabl
ii
presenc
diarrhea
associ
significantli
patient
associ
travel
abroad
myalgia
nausea
fever
multivari
analys
demonstr
cough
ci
p
chill
ci
p
conjunct
hyperemia
ci
p
dyspnea
ci
p
associ
independ
infect
compar
patient
sinc
hrv
second
viru
detect
frequent
swab
sampl
patient
compar
also
posit
hrv
use
univari
analys
fever
p
cough
p
chill
p
nausea
p
frequent
patient
swab
patient
swab
older
vs
p
tabl
ii
multivari
analys
identifi
cough
ci
p
chill
ci
p
associ
independ
infect
prospect
cohort
two
wave
ill
observ
epidem
curv
first
wave
occur
low
preval
contrast
previous
publish
data
casalegno
et
al
b
hrv
could
explain
complet
wave
major
etiolog
agent
identifi
second
wave
occur
correspond
highest
preval
virus
hrv
piv
observ
preval
hrv
detect
commonli
patient
test
patient
result
consist
previou
data
suggest
hrv
one
frequent
caus
acut
respiratori
infect
adult
children
preval
rang
bellei
et
al
ren
et
al
buecher
et
al
renoi
et
al
razanajatovo
et
al
tokarz
et
al
among
differ
hcov
test
hcov
oc
strain
found
sampl
test
preval
similar
studi
report
hcov
nearli
patient
sampl
bellei
et
al
ren
et
al
renoi
et
al
nine
patient
posit
least
one
piv
although
consid
frequent
identifi
piv
henrickson
detect
primarili
similar
find
renoi
et
al
lack
detect
may
due
viru
commonli
identifi
first
year
life
renoi
et
al
pcr
method
use
diagnosi
ev
design
specif
diagnost
central
nervou
system
infect
howev
recent
studi
use
gener
pcr
identifi
novel
respiratori
ev
could
detect
system
design
mening
diagnost
et
al
tapparel
et
al
although
possibl
ev
remain
undetect
five
sampl
test
posit
ev
test
patient
consist
previou
studi
patient
acut
respiratori
infect
ill
bellei
et
al
et
al
ren
et
al
studi
four
sampl
posit
adv
two
sampl
posit
hmpv
preval
compar
previou
report
bellei
et
al
et
al
ren
et
al
absenc
rsv
infect
could
explain
mean
age
year
old
test
popul
delay
epidem
rsv
infect
franc
winter
season
casalegno
et
al
b
clinic
signific
unclear
jartti
et
al
studi
test
swab
posit
one
respiratori
viru
lower
previous
report
esper
et
al
hombrouck
et
al
raboni
et
al
tokarz
et
al
wherea
result
bias
fact
patient
neg
test
virus
pandem
circul
influenza
b
null
limit
respect
renoi
et
al
nakamura
et
al
tokarz
et
al
therefor
patient
neg
ridt
result
test
influenza
b
multipl
clinic
definit
ill
none
satisfactorili
sensit
specif
defin
influenza
viru
infect
thurski
et
al
cdc
although
clinic
present
defin
ill
accord
cdc
definit
cdc
confirm
influenza
laboratori
document
moreov
percentag
patient
swab
differ
significantli
patient
symptom
ill
present
symptom
patient
ill
also
swab
test
posit
hrv
ev
hmpv
adv
piv
hcov
clinic
characterist
patient
infect
report
sever
countri
et
al
ong
et
al
kim
et
al
hombrouck
et
al
lee
et
al
smit
et
al
b
eight
studi
clinic
featur
associ
mostli
cough
fever
sever
studi
report
result
respiratori
viru
test
use
respiratori
sampl
obtain
patient
ill
acut
respiratori
infect
throughout
world
differ
time
although
target
popul
inclus
criteria
season
climat
environ
diagnost
method
number
virus
bacteria
test
differ
proport
case
remain
rel
high
bellei
et
al
et
al
renoi
et
al
conclus
studi
found
mani
respiratori
virus
circul
pandem
franc
ii
viru
circul
impact
kinet
respiratori
virus
iii
percentag
case
remain
high
therefor
justifi
pursu
technic
develop
enlarg
varieti
microorgan
detect
panel
iv
cdc
definit
ill
symptom
capabl
distinguish
viru
respiratori
virus
final
v
specif
criteria
favor
infect
cough
systemat
test
respiratori
virus
necessari
improv
target
appropri
antivir
treatment
specif
studi
explor
preval
clinic
characterist
ii
consequ
differ
microorgan
involv
respiratori
infect
hospit
level
broadli
insid
outsid
hospit
necessari
better
manag
case
